OCT 18, 2018 6:37 AM PDT

Potential Drug Target for Tactile Allodynia

WRITTEN BY: Nouran Amin

According to research published in the journal Science Translational Medicine in collaboration with a study led by the National Institutes of Health, a new protein found in neuronal cells was identified by researchers at Scripps Research to be implicated in tactile allodynia; a painful sensation caused by light touch and often associated with neuropathy.

Watch Video Below To Learn More about Tactile Allodynia:

The protein identified is PIEZO2 which was originally discovered in the laboratory of Professor Ardem Patapoutian, who worked significantly on the role of allodynia in mice. These studies also confirmed that PIEZO2 was responsible for allodynia in humans. “These two studies provide validation that targeting PIEZO2 could be beneficial in the clinic,” explains Prof. Patapoutian.

During the studies, researchers had used various induction methods for allodynia including the utilization of a neuronal sensitive chemical molecule, capsacin, which is found in a chili pepper, and known to cause inflammation. “We hope that these results will help researchers develop better treatments for managing this common form of pain,” said study author Alexander T. Chesler, PhD, who is also a Stadtman Investigator at the NIH’s National Center for Complementary and Integrative Health (NCCIH).

Image via Drug Target Review

Furthermore, first author of the study—Dr. Swetha Murthy had examined the research to focus on mice who had gentle reactions to touch after exposure to capsaicin. Findings concluded that non-genetically altered normal mice had experienced allodynia. However, the mice that were altered, or had the PIEZO2 gene “knocked out”, did not experience allodynia by not reacting to the capsaicin exposure. Additionally, the findings were also exhibited in human patients who had mutations in their PIEZO2 gene expression. “It was very gratifying to see this in both studies,” says Dr. Murthy. “It usually takes years to confirm if results observed in mice hold true in humans, so I think it was mutually exciting for both groups.”

The researchers are looking forward to examine exactly how inflammation is implicated with normal touch signals and to determine a cause. They also wish to identify potential molecules that can act as PIEZO2 blockers that may one day relieve patients from neuropathic pain.

Source: Science Transitional Method, Drug Target Review

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
OCT 19, 2022
Technology
Drug Delivery System: Antibiotic Cement for Treating Bone Infections
OCT 19, 2022
Drug Delivery System: Antibiotic Cement for Treating Bone Infections
Antibiotic resistance continues to be an increasingly worrisome global health problem. Though antibiotics have been foun ...
OCT 21, 2022
Health & Medicine
How The Brain Processes Sensory Information from Internal Organs
OCT 21, 2022
How The Brain Processes Sensory Information from Internal Organs
A study published in Nature provides insight into how the brain processes sensory information from the internal organs. ...
NOV 03, 2022
Neuroscience
Green Eyeglasses Can Reduce Pain-related Anxiety
NOV 03, 2022
Green Eyeglasses Can Reduce Pain-related Anxiety
Researchers have discovered that wearing special green eyeglasses for several hours a day reduces pain-related anxiety. ...
NOV 03, 2022
Drug Discovery & Development
A new vaccine against RSV can protect children from the virus immediately at birth
NOV 03, 2022
A new vaccine against RSV can protect children from the virus immediately at birth
As COVID-19 and flu virus infection rates are on the rise, another virus is now wreaking havoc on the United States ...
NOV 10, 2022
Cardiology
Short Bursts of Activity are Linked to Increased Longevity
NOV 10, 2022
Short Bursts of Activity are Linked to Increased Longevity
A recent study published in the European Heart Journal suggests that short two-minute bursts of activity that add up to ...
NOV 16, 2022
Health & Medicine
C360 Psilocybin Lessens Treatment-Resistant Depression Symptoms
NOV 16, 2022
C360 Psilocybin Lessens Treatment-Resistant Depression Symptoms
Researchers found that psilocybin may have potential as a treatment for those suffering from extreme depression. Psilocy ...
Loading Comments...